Source link : https://newshealth.biz/health-news/fda-broadens-caplyta-approval-to-include-major-depression/
(MedPage Today) — The FDA approved lumateperone (Caplyta) as an adjunctive therapy with antidepressants for the treatment of major depressive disorder in adults, Johnson & Johnson announced. Lumateperone was previously approved as an adjunctive… Source link : https://www.medpagetoday.com/psychiatry/depression/118356 Author : Publish date : 2025-11-06 21:18:00 Copyright for syndicated content belongs to the linked Source.
The post FDA Broadens Caplyta Approval to Include Major Depression first appeared on News Health.
—-
Author : News Health
Publish date : 2025-11-06 21:18:00
Copyright for syndicated content belongs to the linked Source.
—-
1 – 2 – 3 – 4 – 5 – 6 – 7 – 8